Skip to main content

Advertisement

SpringerLink
Log in

Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapy

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Adherence to antiretroviral regimens by HIV-infected patients is necessary to prolong viral suppression and forestall viral resistance. This review covers the major advances made in research on adherence to HIV therapy in the past year. Currently, approximately 40% of patients receiving antiretroviral therapy have significant problems with adherence. Established predictors of poor adherence include depression, alcohol and illicit drug use, poor self-efficacy, and certain health beliefs. Medical providers are poor at predicting adherence. Interventions to improve adherence can have modest effects, and many types of interventions are effective. Multifaceted and repetitive interventions provide the most benefit. Medical providers, as part of the medical management of HIV-infected patients, should use interventions to achieve high levels of adherence to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gulick RM, Mellors JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734–739.

    Article  PubMed  CAS  Google Scholar 

  2. Haas DW, Seekins D, Cooper R, et al.: A phase II, doubleblind, placebo-controlled, dose ranging study to assess the antiretroviral activity and safety of efavirenz (EFV, SustivaTM, DMP 266) in combination with open-label zidovudine (ZDV) with lamivudine (3tc) at 36 weeks [DMP 266-005] [abstract]. In Program and Abstracts of the 12th World AIDS Conference. Geneva, Switzerland 1998:22334.

  3. Deeks S, Loftus R, Cohen P, et al.: Incidence and predictors of virologic failure to indinavir (IDV) and/or ritonavir (RTV) in an urban health clinic [abstract]. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada, 1997:LB-2.

  4. Moore RD, Keruly JC, Chaisson RE: Effectiveness of combination antiretroviral therapy in clinical practice [abstract]. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada, 1997:I–181.

  5. Department of Health and Human Services and the Henry J. Kaiser Family Foundation: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med 1998, 128:1079–1100. A discussion of “adherence to potent antiretroviral therapy” is available as a supplement to the guidelines for the “treatment of HIV infected adult and adolescents” on AIDS Treatment Information Service website at http://www.hivatis.org/trtgdlns.html.

    Google Scholar 

  6. Patterson D, Swindells S, Mohr J, et al.: How much adherence is enough: a prospective study of adherence to protease inhibitor therapy using MEMS Caps [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:092.

  7. Gallant JE, Block DS: Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients. J IntAssoc Physicians AIDS Care 1998, 4:32–35. This article documents the extent of nonadherence among patients taking combination antiretroviral therapy and shows the divergent perceptions of patients and physicians with respect to reasons for nonadherence.

    CAS  Google Scholar 

  8. Lopez-Suarez A, Fernandez-Gutierrez del Alamo C, Perez-Guzman E, et al.: Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS 1998, 12:685–686.

    PubMed  CAS  Google Scholar 

  9. Wenger N, Gifford A, Liu H, et al.: Patient characteristics and attitudes associated with antiretroviral (AR) adherence [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:98. Random sampling, sample size, and multivariate analysis make this an important study of predictors of nonadherence. The full poster is available at www.retroconf.org.

  10. Eldred LJ, Wu AW, Chaisson RE, et al.: Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovir 1998, 18:117–125. This is one of the only published journal articles of a systematic study of medication adherence with multivariate analysis.

    CAS  Google Scholar 

  11. Tuldra A, Ferrer MJ, Rodriguez C, et al.: A proposed model to predict compliance with antiretroviral therapy [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–177.

  12. Cheever LW, Wolf L, Chaisson RE: MEMS devises to measure adherence among HIV infected patients [abstract]. In Abstracts of the Infectious Diseases Society of America 35th Meeting. San Francisco, 1997:239.

  13. Kaplan A, Golin C, Beck K, et al.: Adherence to protease inhibitor therapy and viral load [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:96.

  14. Schultz RM, Mullenix TA, Googe HL, et al.: Depression scores and antiretroviral therapy adherence in HIV disease [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–215.

  15. Cheever LW, Barnes GL, Chaisson RE: A randomized educational intervention to improve adherence with medication [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–178.

  16. Walsh JC, Dalton M, Gill J, et al.: Adherence to highly active antiretroviral therapy (HAART) [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–171.

  17. Roca B, Romero P, Uso J, et al.: Stavudine, lamivudine, and indinavir in drug users and non-drug users: adherence, side effects, and efficacy [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–211.

  18. Sipler AM, Cross JT, Lane DR, et al.: The relationship between literacy, race, and adherence to potent anti-retroviral therapies [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:108.

  19. Berge J, Braun J, Becker S, et al.: Relationship between demographic and clinical disease characteristics and medication adherence among patients in CHORUS. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–212.

  20. Haynes RB: Determinants of compliance: the disease and the mechanics of treatment. In Compliance in Health Care. Edited by Haynes RB, Sackett DL. Baltimore: Johns Hopkins University Press; 1979:49–62.

    Google Scholar 

  21. Demasi R, Tolson J, Pham S, et al.: Self-reported adherence to HAART and correlation with HIV RNA: initial results with the patient medication adherence questionnaire [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:94.

  22. Muma RD, Ross MW, Parcel GS, et al.: Zidovudine adherence among individuals with HIV infection. AIDS Care 1995, 7:439–447.

    Article  PubMed  CAS  Google Scholar 

  23. Thomas SB, Curran JW: Tuskegee: from science to conspiracy to metaphor. Am J Med Sci 1999, 317:1–4.

    Article  PubMed  CAS  Google Scholar 

  24. Siegel K, Gorey E: HIV-infected women: barriers to AZT use. Soc Sci Med 1997, 45:15–22.

    Article  PubMed  CAS  Google Scholar 

  25. Bangsberg DR, Hecht FM, Charlebois EC, et al.: Spontaneous adherence (ADH) audits (SAA) predict viral suppression in the REACH cohort [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:93.

  26. Stewart KE, Greene P, Call S, et al.: Patterns of self reported adherence to ART in a prospective clinical cohort [abstract]. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–176.

  27. Golin C, Liu H, Hays R, et al.: Self-reported adherence to protease inhibitors substantially overestimates an objective measure [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:95.

  28. Hales G, Mitchell J, Smith DE, et al.: Validity of patient questioning versus pill count as an assessment of compliance [abstract]. In Program and Abstracts of the 12th World AIDS Conference. Geneva, Switzerland, 1998:32373.

  29. Melbourne K, Geletko S, Brown S, et al.: Electronic adherence assessment versus self-report in HIV-infected individuals. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 1998:I–175.

  30. Chesney MA: New antiretroviral therapies: adherence challenges and strategies [abstract]. In Evolving HIV Treatments: Advances and the Challenge of Adherence Symposium. Toronto: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997.

  31. Niewkerk P, Gisolf EH, Van Leeuwen R, et al.: Self-reported adherence to ritonavir/saquinavir and ritonavir/saquinavir/ stavudine in a randomized clinical trial: preliminary results [abstract]. In Program and Abstracts of the 12th World AIDS Conference. Geneva, Switzerland, 1998:32362.

  32. Sackett DL, Haynes RB, Gibson ES, et al.: Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1976, 1:1265–1268.

    PubMed  Google Scholar 

  33. Ickovics J: Behavioral measures. In Adherence to New HIV Therapies: A Research Conference. Washington, DC: National Institutes of Health Office of AIDS Research; 1997:15–18. This reference is from the proceedings of a national meeting of adherence. The document has an excellent review of the greater adherence literature with specific discussions of research concerns such as measures of adherence.

    Google Scholar 

  34. Davis MS: Variations in patients’ compliance with doctors’ orders: analysis of congruence between survey responses and results of empirical investigations. J Med Edu 1966, 41:1037–1048.

    CAS  Google Scholar 

  35. Miller L, Liu H, Beck K: Providers’ estimates of adherence overestimate reports from medication event monitoring system (MEMS) for patients on protease inhibitors (PIs) [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 1999:97.

  36. Haynes RB, McKibbon KA, Kanani R: Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996, 348:383–386.

    Article  PubMed  CAS  Google Scholar 

  37. Roter DL, Hall JA, Merisca R, et al.: Effectiveness of interventions to improve patient compliance a meta-analysis. Med Care 1998, 36:1138–1161. This meta-analysis, which is quite technical in its analysis, shows the relative effectiveness of adherence interventions.

    Article  PubMed  CAS  Google Scholar 

  38. Knobel H, Carmona A, Grau S, et al.: Strategies to optimise adherence to highly active antiretroviral treatment [abstract 338/32322]. In Program and Abstracts of the 12th World AIDS Conference. Geneva, Switzerland, 1998.

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, School of Medicine, Johns Hopkins University, 1830 East Monument Street, Room 449, 21287, Baltimore, MD, USA

    Laura W. Cheever MD & Albert W. Wu MD, MPH

Authors
  1. Laura W. Cheever MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert W. Wu MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheever, L.W., Wu, A.W. Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapy. Curr Infect Dis Rep 1, 401–407 (1999). https://doi.org/10.1007/s11908-999-0049-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-999-0049-8

Keywords

Search

Navigation